New VectoMax Biological Larvicide for Mosquito Control


Valent BioSciences Corporation Launches New VectoMax® Biological Larvicide for Mosquito Control

LIBERTYVILLE, IL., March 26, 2009 — Valent BioSciences Corporation will be introducing a new, advanced biological larvicide for mosquito control professionals worldwide.

The new product VectoMax® Biological Larvicide will be launched officially at the American Mosquito Control Association’s 2009 annual meeting next week in New Orleans.

Developed through extensive research efforts, VectoMax provides control of all mosquitoes through the actions of two naturally occurring microbial species, Bacillus thuringiensis subsp. israelensis (Bti) and Bacillus sphaericus (Bsph). Bti and Bsph are combined into every micro-particle for ingestion by mosquito larvae. With each bite, larvae are exposed to the entire suite of Bti and Bsph toxins, resulting in quick kill of all mosquito species and extended residual in many habitats.

The key to the new product’s broad-spectrum, long-lasting mosquito control lies within Valent BioSciences Corporation’s proprietary BioFuseTM technology that combines Bti and Bsph toxins into every micro particle during the manufacturing process. VectoMax is not a mixture of Bti and Bsph, but a unique combination of Bti and Bsph optimized to control all mosquito species.

“In the United States, mosquito control professionals have expressed interest in a microbial product that combines the fast acting, broad spectrum aspects of Bti with the long residual control offered by Bsph,” said Ernest Dankwa, Senior Global Business Manager with Valent BioSciences Corporation. “Extensive, large-scale field research at locations around the world shows VectoMax can meet those needs.”

VectoMax is available in the United States in both granule (G, CG) and water-soluble pouch (WSP) formulations in 2009. For more information, contact Valent BioSciences Corporation toll-free at 800-323-9597, or visit the company’s Web site,

About Valent BioSciences Corporation
About Valent BioSciences Corporation: Headquartered in Libertyville, IL, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Company. Valent BioSciences is the worldwide leader in the development, manufacturing and commercialization of biorational products, with sales in 95 countries around the world. Valent BioSciences is an ISO 9001:2008 Certified Company. For additional information, visit the company’s website at

Media Contact:
Barbara Wendling
Valent BioSciences Corporation

Download Press Release


Related News

Valent BioSciences LLC announces its acquisition of FBSciences Holdings, Inc., a leader in the discovery and commercialization of naturally derived plant, soil, and climate health solutions.
The new solar field at Valent BioSciences’ manufacturing facility in Osage, Iowa, is now fully operational.
Valent BioSciences LLC, the global biorational products leader in agriculture, public health, and forest health, has announced that the company began selling biostimulant products directly to its U.S. customer base on October 1.
Sumitomo Chemical Co., Ltd. (SCC), parent company of Valent U.S.A. and Valent Biosciences, today announced a new entity called Valent North America that will provide enterprise business services across the Valent group of companies. 
Valent BioSciences LLC, the global biorational products leader in agriculture, public health, and forestry, has announced the promotion of Salman Mir to Executive Vice President and Chief Operating Officer. He will continue reporting to Ted Melnik, Valent BioSciences’ President and Chief Executive Officer.
To promote its industry leadership in biorational and biostimulant product innovation, Valent BioSciences LLC has announced significant investments at several of its key research and development facilities.